Corbus Pharmaceuticals (CRBP) CEO: Breaking Down The Data | Mad Money: CNBC

CNBC

Published on Nov 23, 2016

Jim Cramer spoke with CEO Yuval Cohen on the company’s recent drug trial results for Resunab, and where it sees the future headed.

http://www.4-traders.com/CORBUS-PHARMACEUTICALS-HO-21683508/